Selected Track Record
Cross-border execution from multi-center clinical collaboration to commercial-scale biomanufacturing and supply.
Cross-Border Licensing & Market Access for a Phase III AAV Gene Therapy
Novel Gene Therapy · Multi-Center Clinical Trials
Sterile Tube Welding Systems & Consumables for Blood and Plasma Centers
Sterile Tube Welding · Matched Consumables · Steady Supply
Sterile Tube Welders & Automated CAR-T Equipment for Japanese Pharma and CDMOs
Tube Welders · All-in-One & Modular CAR-T Systems · Pharma & CDMOs
Technology Licensing & Commercial Scale-Up for Single-Cell Protein (SCP)
Biomanufacturing IP Licensing · 1,000L Pilot-to-Commercial Scale-Up · Line Engineering
Automated Manufacturing Process & Modular Platform for a Clinical-Stage Cell Therapy
Regenerative Medicine · Automated Cell Processing · Modular Platform
Cross-Border Licensing & Market Access for a Phase III AAV Gene Therapy
Novel Gene Therapy · Multi-Center Clinical Trials
Facilitated the cross-border out-licensing of a proprietary Phase III AAV gene therapy developed in China. Coordinated the licensee's Phase III bridging clinical trials in target EAEU jurisdictions, alongside clinical supply and post-approval commercial drug supply.
Sterile Tube Welding Systems & Consumables for Blood and Plasma Centers
Sterile Tube Welding · Matched Consumables · Steady Supply
Supplied integrated high-precision sterile tube welders and matched single-use consumables to national and commercial blood centers, apheresis centers, and hospitals, supported by ongoing technical maintenance and local service to safeguard closed-system sterility.
Sterile Tube Welders & Automated CAR-T Equipment for Japanese Pharma and CDMOs
Tube Welders · All-in-One & Modular CAR-T Systems · Pharma & CDMOs
Met strict aseptic closed-system and compliance standards for leading Japanese pharmaceutical manufacturers and CDMOs, delivering validated precision sterile tube welders, All-in-One CAR-T systems, modular processing equipment, and matched sterile consumables for commercial operations.
Technology Licensing & Commercial Scale-Up for Single-Cell Protein (SCP)
Biomanufacturing IP Licensing · 1,000L Pilot-to-Commercial Scale-Up · Line Engineering
Advanced cross-border IP licensing and industrial collaboration for a synthetic biology single-cell protein (SCP) biomanufacturing platform, supporting process engineering, core equipment selection, and commercial line development from 1,000L pilot validation to commercial scale.
Automated Manufacturing Process & Modular Platform for a Clinical-Stage Cell Therapy
Regenerative Medicine · Automated Cell Processing · Modular Platform
Supported a Swiss biotech company's transition from manual handling to closed, automated cell therapy manufacturing, co-developing modular process units covering cell encapsulation, dynamic culture, automated harvesting, and aseptic filling to enable progression toward commercial-scale cGMP manufacturing.
Start a Cross-Border
Biopharma & Biotech Collaboration
Whether you are exploring cross-border pipeline licensing, custom automated bioprocess equipment, or supply chain integration in China, we welcome your inquiry. A managing partner for the relevant practice will respond within 3 business days.